Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	421	253	259	453	591	359
Market Cap Growth	51.18%	-2.48%	-42.79%	-23.38%	64.89%	-6.41%
Enterprise Value	467	295	269	403	560	289
Last Close Price	24.31	14.50	15.00	26.50	35.00	21.40
PS Ratio	2.71	2.18	2.24	3.27	5.44	6.05
PB Ratio	-19.45	-8.83	-19.04	14.92	17.38	6.67
P/TBV Ratio	-	-	-	14.92	17.38	6.67
P/FCF Ratio	39.95	-	-	86.30	-	-
P/OCF Ratio	39.92	-	-	77.10	-	-
EV/Sales Ratio	2.97	2.55	2.33	2.90	5.15	4.88
EV/FCF Ratio	43.60	-	-	76.67	-	-
Debt / Equity Ratio	-6.85	-3.64	-6.44	3.00	1.15	0.67
Debt / FCF Ratio	9.35	-	-	17.38	-	-
Asset Turnover	1.24	0.92	0.77	1.00	0.84	0.41
Inventory Turnover	5.26	2.17	5.17	10.82	12.21	20.50
Quick Ratio	1.69	1.64	1.51	2.21	1.79	1.86
Current Ratio	1.96	1.86	1.78	2.43	2.18	2.04
Return on Equity (ROE)	-	-	-699.05%	-55.63%	-67.72%	-81.73%
Return on Assets (ROA)	4.61%	-10.73%	-24.34%	-8.77%	-14.04%	-30.13%
Return on Capital (ROIC)	7.43%	-18.03%	-37.50%	-12.50%	-22.19%	-43.18%
Earnings Yield	0.91%	-9.92%	-22.59%	-3.95%	-5.03%	-18.65%
FCF Yield	2.50%	-2.27%	-28.62%	1.16%	-9.04%	-11.98%
Buyback Yield / Dilution	-1.13%	-0.93%	-1.12%	-1.03%	-0.81%	-4.28%
Total Shareholder Return	-1.13%	-0.93%	-1.12%	-1.03%	-0.81%	-4.28%

Source: S&P Capital IQ. Standard template. Financial Sources.